Pembrolizumab demonstrated clinical activity in patients with mycosis fungoides (MF) and Sézary syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma (CTCL), with nearly half of ...

Mycosis fungoides (MF) is the most common type of ... Photopheresis is an option for SE9zary syndrome, a variant of MF. With treatment and regular check-ups remission may be achieved and the ...

Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat ...